Six UAE Research Projects Receive AED 4 Million in Grants to Drive Innovation in MS Care and Treatmen Abu Dhabi, 19 May 2025 – The National Multiple Sclerosis Society (NMSS) has awarded AED 4 million in research grants to six UAE-based projects designed to accelerate progress in the understanding, diagnosis, and treatment of multiple sclerosis (MS), marking a major milestone in its second research grant cycle. The projects were selected with input from key stakeholders, including the Department of Health – Abu Dhabi (DOH), highlighting ongoing efforts to build momentum around MS research and advocacy in the UAE. The announcement comes alongside the release of the NMSS 2023–2024 Research Impact Report. This year's funding has doubled compared to the inaugural cycle, reflecting NMSS’s strengthened ......read more

Pioneer treatment Indicates 61% Pain Reduction in Patients Undergoing Umbilical Cord Stem Cell Treatment Abu Dhabi, UAE – May 6th, 2024: Abu Dhabi Stem Cells Center and Yas Clinic Khalifa Hospital are proud to announce groundbreaking findings on innovative treatments for chronic lower back pain caused by facet joint arthritis. This condition affects up to 45% of individuals suffering from chronic lower back pain, and the treatment’s results offer new hope for patients battling this debilitating issue.  Dr. Maysoon Al Karam, Chief Medical Officer at Abu Dhabi Stem Cells Center said: “The effectiveness of two treatments are incredible: Umbilical Cord Mesenchymal Stem Cells (UC-MSC) and Peripheral Blood-Derived Monocytes. Facet joint arthritis, which causes the deterioration of spine joints, has few ......read more

With 16 teams participating in the 'Smart Living' and 'The Gym of Tomorrow' categories, breakthrough health-tech solutions were recognised at the event Winning teams will receive prizes of up to $5000, mentorship, and pilot opportunities in Abu Dhabi's trusted, future-ready health ecosystem The ADGHW Smart Health Hackathon tasked participants with developing cutting-edge solutions to address specific health and well-being challenges Abu Dhabi, UAE, 18 April 2025 – Abu Dhabi Global Health Week (ADGHW) has announced the winners of its highly anticipated Smart Health Hackathon. Held from 5 – 6 April 2025, the innovation sprint brought together talented entrepreneurs, university teams, health-tech professionals, and inventors in the UAE capital to develop pioneering solutions to critical ......read more

Abu Dhabi, 28 March 2025: The Department of Health – Abu Dhabi (DoH) has announced the introduction of CASGEVY, the first CRISPR/Cas9 gene-editing therapy in the UAE, offering innovative treatment for patients suffering from sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). The innovative treatment, provided by Abu Dhabi Stem Cells Center (ADSCC), in coordination with DoH and in collaboration with Vertex Pharmaceuticals, a leading biotechnology company, positions Abu Dhabi as a leading destination for life sciences.  The first patient is scheduled to begin the groundbreaking therapy at Yas Clinic Hospital in April of this year. CRISPR/Cas9 gene-editing is an innovative technology that enables precise genome editing to treat certain genetic diseases by targeting and altering specific DNA ......read more

Abu Dhabi, 10 March 2025: Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have been granted a highly regarded global accreditation by AABB (formerly known as the American Association of Blood Banks) for Hematopoietic Progenitor Cell Collection. This achievement marks ADSCC and Yas Clinic as the first to earn this accreditation in the UAE, and the second in the Middle East and North Africa region (MENA), meeting the highest standards of quality and safety in in the procurement, processing, and storage of hematopoietic progenitor cells, which are critical for transplantation and treating various blood disorders and autoimmune diseases. As a Centre of Excellence in Hematopoietic Stem Cell Transplantation, accredited by  the Department of Health Abu Dhabi and an accredited facility by the Foundation of Accreditation for Cellular ......read more

Abu Dhabi, February 19, 2025: Prometheus Medical International, experts in providing emergency medical training services in the Middle East, is showcasing its cutting-edge medical training capabilities in the defence and military sector at IDEX 2025, currently under way in Abu Dhabi. The company also hosted a Medical Workshop on CBRNE (Chemical, Biological, Radiological, Nuclear, and Explosives) led by Stuart Ward, a distinguished expert in CBRNE defence and medical training, as part of IDEX Talks Programme during the exhibition. The talk focused on emergency medical training, emergency response, and CBRNE scenarios.

...read more

Abu Dhabi, 2 January 2025: In a groundbreaking advancement toward cell therapy and regenerative medicine, the Abu Dhabi Stem Cells Center (ADSCC) has successfully developed clinical-grade induced pluripotent stem cells (iPSCs) that comply with the Good Manufacturing Practice protocols and are, as such, compliant with the strictest international standards for clinical applications. This has been accomplished by the scientists at ADSCC’s research laboratories in Abu Dhabi using their virus-free in-house, exclusive techniques, know-how and protocols. The achievement, the first of its kind in the Middle East, positions ADSCC as a pioneer in stem cell research, setting a global benchmark for innovation and safety in precision medicine. iPSCs are a cutting-edge innovation in biomedical science, to be used for a wide range of ......read more

The Abu Dhabi Stem Cells Center (ADSCC) has successfully performed the UAE’s first testicular tissue cryopreservation (TTC) procedures on four young boys, aged 2 to 10, prior to their bone marrow transplants. This groundbreaking procedure preserves the children’s future fertility while undergoing life-saving treatments for conditions such as leukemia, thalassemia, and immunodeficiency diseases. The procedures, conducted with the consent and support of the children's families, involved a multidisciplinary team of experts, showcasing ADSCC's commitment to innovative pediatric care. Testicular tissue samples were carefully preserved for potential future use, ensuring long-term quality of life for the patients. ADSCC continues to set new standards in healthcare excellence through its pioneering Abu Dhabi Bone Marrow ......read more

The procedure preserves the future fertility of the young boys prior to undergoing Bone Marrow Transplant to treat blood disorders and immunodeficiency diseases Abu Dhabi, UAE – December 30, 2024: The Abu Dhabi Stem Cells Center (ADSCC) has successfully performed four testicular tissue cryopreservation (TTC) procedures on four young patients (2, 7, 4 and 10 years-old respectively) prior to undergoing Bone Marrow Transplantation to treat their diseases. Two of the boys suffered from immunodeficiency diseases, one was diagnosed with leukemia and the other with thalassemia. Launching this innovative medical advancement for the first time in the UAE reflects ADSCC's commitment to provide comprehensive innovative care for young patients and advanced pediatric bone marrow transplant care. The success of these procedures ......read more

Biongevity introduces its one-of-a-kind initiatives to promote longevity and healthspan of users across the UAE Date: Dubai, UAE; November 11, 2024 Biongevity, a leader in innovative health solutions, has unveiled an advanced AI-powered health and wellness app, a platform designed to empower users with personalised fitness and health management tools and the world’s first Longevity Fitness Challenge that will encourage the UAE’s population in making health and fitness a daily priority. Biongevity is a leading healthcare facility in Dubai that focuses on longevity genetics and precision medicine, offering solutions which help consumer live long through a preventive life-cycle management that extends the life span of individuals with less medical intervention. The launch of its initiatives is underpinned by the ......read more

This move underscores Mubadala's commitment to supporting the UAE's vision of becoming a global leader in the life sciences sector. The acquisition of four GlobalOne Healthcare Holding assets by KELIX Bio represents Mubadala's ongoing strategic investment in the UAE's life sciences ecosystem. This acquisition further supports KELIX bio's regional growth and strengthens its position in the UAE.  Abu Dhabi, 14 October 2024 – Following the closing of the acquisition of KELIX bio, Mubadala Investment Company PJSC "Mubadala", an Abu Dhabi sovereign investor, has empowered its new specialty pharmaceutical business to acquire a 100% stake in four of GlobalOne Healthcare Holding's (GHH) pharma assets which include Bioventure, Bioventure Healthcare, Gulf Inject and ......read more

This technology is revolutionising kidney stone treatment, doubling the speed and enhancing safety and effectiveness over traditional methods Al Ain, UAE. 26 September 2024 – Tawam Hospital’s Department of Urology is at the forefront of medical innovation with the introduction of the Thulium SuperPulsed Laser System to treat a 68-year-old patient with recurrent kidney stones. After years of painful episodes and undergoing various treatments, the patient experienced significant relief through this cutting-edge technology. The Thulium SuperPulsed Laser System is redefining the management of kidney stones by offering a procedure that is twice as fast as traditional methods. Its ability to provide quicker, safer, and more effective treatment marks a significant advancement in patient care. This technological breakthrough ......read more

Renowned Geneticist Dr. Libero Oropallo Brings Cutting-Edge Solutions to Patients Worldwide In a world where rare diseases often go undiagnosed and untreated, Dr. Libero Oropallo has emerged as a beacon of hope for countless patients and their families. Hailing from Italy but currently practicing in Paraguay, Dr. Oropallo is making waves in the field of genetics, combining his exceptional knowledge, experience, and compassion to provide life-changing care. Dr. Oropallo's journey began with an unwavering curiosity about the human genome. After completing his advanced studies in genetics and medicine, he quickly became a specialist in identifying and treating some of the most complex and rare genetic disorders. What sets Dr. Oropallo apart is not just his profound expertise but also his personalized approach to each patient, ......read more

Procedure marks a significant milestone in paediatric cardiac care within the UAE. Abu Dhabi-UAE. 17 September 2024 – Doctors at Sheikh Khalifa Medical City (SKMC) have successfully implanted an Occlutech Atrial Flow Regulator (AFR) device in a five-year-old patient in the first such procedure in the UAE. The intervention has significantly improved the patient's condition in a milestone for paediatric cardiac care under SEHA, a subsidiary of PureHealth, the largest healthcare platform in the Middle East. Following an extended period of hospitalisation due to prolonged fluid accumulation in the chest after cardiac surgery, the child’s condition required an advanced solution to improve the flow of blood around his circulation. The successful procedure involved the keyhole placement of the AFR device, a special ......read more

The 36-year-old patient presented at MZH with abdominal discomfort and was diagnosed with a 10 cm cystic mass on their right adrenal gland. Abu Dhabi, UAE – 9 September 2024 – The surgical team at Madinat Zayed Hospital (MZH), part of the SEHA and a subsidiary of PureHealth, the largest healthcare platform in the Middle East, has successfully carried out a complex laparoscopic right adrenalectomy on a 36-year-old patient suffering from a large adrenal cyst. This operation highlights the advanced surgical proficiency and world-class healthcare services available across SEHA's extensive network, including the Al Dhafra region. The patient, who reported to MZH with abdominal discomfort, was diagnosed with a 10 cm cystic mass on the right adrenal gland. An exhaustive preoperative evaluation, which included a CT scan, ......read more

Opening 12 clinics in a single location, SEHA’s new state-of-the-art facilities will make the patient experience faster and smoother. Abu Dhabi - 4 September 2024: SEHA, a subsidiary of PureHealth, the largest healthcare platform in the Middle East, has announced the re-opening of the outpatient clinics at Al Rahba Hospital under its dedication to community wellbeing. The hospital’s outpatient department has undergone an extensive renovation to offer clinical facilities in line with SEHA’s commitment to providing the highest quality healthcare services. The opening of the enhanced outpatient clinic marks an important step in SEHA’s ongoing work to boost community access to healthcare in Abu Dhabi in line with the emirate’s strategy to create a world-leading healthcare system. Saif Al Siksek, Acting ......read more

New findings can help design protective habitats and spacesuits, making long-duration Mars missions more feasible Abu Dhabi, August 26, 2024: Researchers have identified specific materials, including certain plastics, rubber, and synthetic fibers, as well as Martian soil (regolith), which would effectively protect astronauts by blocking harmful space radiation on Mars. These findings could inform the design of protective habitats and spacesuits, making long-duration Mars missions more feasible. Because Mars lacks Earth’s thick atmosphere and magnetic field, astronauts exploring the planet would be exposed to dangerous levels of radiation. Dimitra Atri, Investigator, Center for Astrophysics and Space Science and Group Leader of the Mars Research Group at NYU Abu Dhabi's Center for Astrophysics and Space Science, and lead ......read more

The patient, initially diagnosed with TB, experienced unexpected complications that were promptly identified as symptoms of a severe pulmonary embolism by Al Ain Hospital's medical team Abu Dhabi-UAE. 20 August 2024: In a remarkable display of medical expertise and prompt intervention, SEHA, a subsidiary of PureHealth, the largest healthcare platform in the Middle East, has successfully managed and treated a critical case at Al Ain Hospital (AAH) where a routine tuberculosis (TB) diagnosis escalated into a life-threatening pulmonary embolism. The patient, initially diagnosed with TB, experienced unexpected complications, which were identified by the Al Ain Hospital medical team as symptoms of a severe pulmonary embolism. This timely diagnosis and subsequent treatment in the Intensive Care Unit (ICU) led to a full recovery, ......read more

New device makes blood transfusions safer for recipients by blasting blood with X-rays. Abu Dhabi-UAE. 06 August 2024 –SEHA, a subsidiary of PureHealth, the largest healthcare platform in the Middle East, announced the introduction of a state-of-the-art blood irradiator at Abu Dhabi Blood Bank Services. The advanced medical device marks a significant milestone in enhancing blood safety and quality standards in the region. The RS 3400 X-Ray Blood Irradiator utilises X-ray irradiation to treat blood and blood components, significantly reducing the risk of Graft Versus Host Disease (GVHD) in patients receiving blood transfusions. This potentially life-threatening complication occurs when white blood cells from the donated blood attack the recipient's body. Unlike traditional irradiators that use radioactive materials like ......read more

Abu Dhabi - 25 July 2024 – Sheikh Khalifa Medical City announced its success in saving a woman who suffered a burst fracture of the T1 vertebra due to car accident. Despite the complexity of the case, the neurosurgery team, led by Dr. Rajeswaran, was able to perform a series of emergency procedures to relieve pressure on the spine. Their prompt and coordinated actions reflect Sheikh Khalifa Medical City’s commitment to providing the highest level of care in the shortest possible time. The patient was discharged from the hospital and able to walk without assistance just one week after arriving at the emergency department at Sheikh Khalifa Medical City, a SEHA hospital, part of Pure Health, the largest healthcare group in the Middle East. “Our team's quick and coordinated response was crucial in turning a ......read more

New understanding can be utilized to develop more effective treatments for hard-to-treat cancers and neurodegenerative diseases Abu Dhabi, July 22, 2024: A team of researchers at NYU Abu Dhabi, led by Professor Sehamuddin Galadari, has discovered that the tumor suppressor protein Prostate apoptosis response-4 (Par-4) can cause a unique type of cell death called ferroptosis in human glioblastoma – the most common and aggressive type of brain tumor – while sparing healthy cells. This new understanding has the potential to inform the development of novel treatments for various hard-to-treat cancers and neurodegenerative diseases. Ferroptosis is triggered by the iron-mediated production of reactive oxygen species (ROS) and subsequent lipid peroxidation, which plays a crucial role in shrinking cancerous tumors. This is the ......read more

Get comprehensive health assessments, including blood pressure and sugar tests and dietician consultations, ensuring your all-round well-being at ADSS. Enjoy a wide range of activities, from football to inflatable obstacle courses, suitable for all ages and fitness levels. Discover the kids’ summer camps and special hotel offers, making ADSS and AASS the ultimate summer destination. Abu Dhabi, UAE:  July 19, 2024 – Capital 360 Event Experiences in partnership with the Abu Dhabi Sports Council has delivered the third edition of the Abu Dhabi Summer Sports (ADSS) and Al Ain Summer Sports (AASS), providing an unparalleled experience in health and wellness, with a variety of offerings that cater to everyone, irrespective of age or fitness level. Running from June 14 to August 23 at ADNEC Centre Abu Dhabi and from ......read more

Abu Dhabi, United Arab Emirates, 10 July 2024: Tawam hospital recently demonstrated the remarkable expertise of its medical team with their timely intervention in saving the life of a 15-year-old Emirati boy who was in critical condition following a severe car accident that resulted in significant brain haemorrhage. The young patient, who had fallen into a coma and was unresponsive, was swiftly transported to Tawam Hospital’s emergency department, part of the Abu Dhabi Health Services Company (SEHA). The hospital's skilled medical emergency trauma team in the children's emergency unit implemented advanced resuscitation techniques to stabilise the boy. An urgent CT scan revealed a severe brain haemorrhage, placing substantial pressure on delicate brain tissues and posing an immediate threat to his life. The young ......read more

‘I Deserve A Life’ initiative focuses on cancer prevention, as well as accessibility to healthcare for patients across the emirate The authority’s Social Investment Fund is targeting AED 1M in funds from individuals and corporations to support the initiative led by Emirates Cancer Society The Memorandum of Understanding was signed and stipulates the Authority of Social Contribution – Ma’an and Emirates Cancer Society’s partnership in making a critical impact on the lives of cancer patients in Abu Dhabi Abu Dhabi, UAE, 8 July 2024: The Authority of Social Contribution – Ma’an, in partnership with Emirates Cancer Society, is encouraging community members and corporates to contribute to improve the overall wellbeing of the community by dedicating funds towards its ‘I Deserve ......read more

Cotterill is the first woman to lead an international health insurance company in the UAE. In her new role, she will be responsible for driving strategic growth across the region's key markets, outside the Kingdom of Saudi Arabia. Dubai, UAE, 02 July 2024 - Cigna Healthcare, the leading global health services company, today announced Leah Cotterill as the new Chief Executive Officer (CEO) for Cigna Healthcare – Middle East and Africa (outside KSA). Cotterill becomes the first female CEO to lead an international health insurance company in the UAE, marking a significant milestone for the industry. The announcement aligns closely with the UAE’s commitment to including more women in leadership roles and fostering gender equality. In her new role, Cotterill will drive the organization’s strategic growth and ......read more

The Program is a key facet of the ‘Building Women’s Skills and Abilities’ service Abu Dhabi, June 25, 2024: The Family Development Foundation (FDF) successfully concluded its innovative ‘100 Days Sports Challenge Program’ aimed at fostering active participation of women and bolstering their skills in sports, health, and education across Abu Dhabi. As a key component of the ‘Building Women’s Skills and Abilities’ service, the initiative also focused on enhancing the psychological well-being of women by positively shaping their familial and social connections. Khawla Al Mehairi, Head of the Women Empowerment Department at the FDF, reiterated the foundation’s commitment to empowering women and nurturing their balanced development through the ‘Building Women's Skills and ......read more

38,000 sqm facility in Al Ain will capture up to 1,000 metric tonnes of CO2 annually, using carbon from local industries to grow microalgae Abu Dhabi, UAE – 20 June 2024: Khalifa Economic Zones Abu Dhabi – KEZAD Group, the largest operator of integrated and purpose-built economic zones, and Astha Biotech, a UAE-based investment and development company, today signed a lease agreement for a new facility in KEZAD Al Ain. The agreement, signed at the Make It In The Emirates Forum 2024, will witness the launch of the first UAE company focused on the production of microalgae with high-value applications across the health, cosmetics, food, and aquaculture industries with an initial investment from Astha Biotech of AED 44 million ($12 million). The Astha Biotech facility, which will spread over 38,000 sqm, will capture up to ......read more

Abu Dhabi-UAE, May 31, 2024: The Foundation for the Accreditation of Cellular Therapy (FACT) announced today that Abu Dhabi Stem Cells Center (ADSCC) has received the internationally recognized FACT accreditation for its comprehensive cellular therapy program. Under the leadership of its Chief Executive Officer Prof. Yendry Ventura, ADSCC is the first healthcare institution in the UAE to be recognized by FACT, positioning the UAE as a leading destination for cutting-edge medical advancements in the region. Out of the 261 centers worldwide accredited by FACT for cellular therapy, ADSCC stands as one of only two centers in the entire Middle East to meet FACT’s rigorous standards. This accomplishment solidifies ADSCC's position as a leader in advanced cellular therapy. The center achieved FACT accreditation ......read more

Introducing a Unique Multi-Sensory Healing Experience, Medcare Royal Speciality Hospital has been dedicated to citizens of the world. Key Highlights: Location: Situated in Al Qusais, just 10 minutes from Dubai International Airport, this 126-bed advanced care facility integrates over 30 specialties under one roof, combining advanced medical care with a multi-sensory healing experience in a luxurious setting. Expert Team: The hospital is bringing in 83 doctors with local and international expertise and is equipped with advanced digital technology for enhanced patient care and management, including AI-enabled diagnostic solutions, remote monitoring and consultation, electronic medical records (EMR) and real-time disease management. Dubai, UAE, 30th May 2024: His Highness Sheikh Rashid Bin Hamdan Al Maktoum inaugurated the ......read more

Abu Dhabi, UAE, 28 May 2024 – Under the patronage of H.H. Sheikha Fatima bint Mubarak, Chairwoman of the General Women's Union, President of the Supreme Council for Motherhood and Childhood, Supreme Chairwoman of the Family Development Foundation, and Mother of the Nation, the 6th Annual International Patient Experience Symposium 2024, will take place May 27-29, in Abu Dhabi, with Sheikh Shakhbout Medical City (SSMC) participating as presenting partner. With the Department of Health Abu Dhabi as a strategic partner, along with several UAE and regional health care entities, this year's symposium is themed ‘Transformative Empathy: Where Care Meets Innovation’. Discussion topics at this year’s event include integration of creativity into care, the impact of technology on patient experience, nursing ......read more

Abu Dhabi, May 26, 2024: The 10th edition of the International Conference in Dermatology and Aesthetics (AIDA) has focused on new developments in dermatology, including the use of biologics to treat some intractable diseases, using AI to treat dermatological diseases, and modern and safe laser and injection techniques in aesthetic medicine. On its final day, AIDA proposed that the UAE should intensify its collaboration with the public and private sectors, and engage with pharmaceutical companies to develop biologics for the treatment of skin diseases such as psoriasis, eczema and severe alopecia. This is because the UAE is one of the first countries to provide new and innovative treatments to patients in a more expedient and effective manner, thereby enhancing patient access to essential medicines. It also underscored the ......read more

AHS expands provision of more than ten specialities to make speciality care easier and more convenient to access for the Abu Dhabi and Al Ain communities. Abu Dhabi-UAE. 20 May 2024: Ambulatory Healthcare Services (AHS), a subsidiary of PureHealth, the largest healthcare platform in the Middle East, is increasing availability of specialist services at its centres and extending opening hours across its network to provide enhanced patient care in Abu Dhabi and Al Ain. The move is in line with its commitment to providing an accessible and seamless patient experience, supporting PureHealth’s strategic objectives to enhance the healthcare ecosystem in Abu Dhabi. AHS provides family medicine, specialty, screening, and diagnostic services across a network of 30 centres throughout the emirate. It has expanded access to more than ten ......read more

Both Acting CEO and Chair of SSMC’s Pediatric Endocrinology Division to Take Part in Panel Discussions Abu Dhabi, UAE, 09 May 2024: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and member of the PureHealth network, will be a participant, exhibitor and sponsor of Abu Dhabi Global Health care Week 2024, which is hosted by the Department of Health – Abu Dhabi (DoH), the regulator of the health care sector in the emirate, under the patronage of H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council. The event will take place at Abu Dhabi National Exhibition Centre, May 13–15, 2024 with the aim of redefining the future of health care and life sciences for a healthier world. As part of the ......read more

Abu Dhabi will host MiPharma Global Conference from 7-10 May. The event will take place at Conrad Abu Dhabi Etihad Towers. Hosted by Etihad Cargo and sponsored by the Department of Culture and Tourism – Abu Dhabi, the conference will underscore Abu Dhabi's critical role in the global pharmaceutical supply chain and its status as an emerging international healthcare hub. The four-day event will provide participants with access to subject matter experts and encourage vertical collaboration to enhance and streamline the pharmaceutical industry's logistics model. Abu Dhabi, United Arab Emirates — Etihad Cargo, the cargo and logistics arm of Etihad Airways, will host the MiPharma Global Conference to support the global pharmaceuticals sector. The event, sponsored by the Department of Culture and Tourism – ......read more

Patient making full recovery following innovative robotic-assisted surgical procedure Abu Dhabi, 07 May 2024: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s leading hospitals for serious and complex care and member of the PureHealth network, today announced a new milestone in the hospital’s use of definitive surgical repair using robotic surgery; successfully treating a patient suffering from complications related to multiple gallstones and features of acute cholecystitis. The surgery, led by Dr. Salem Al Harthi, consultant and chair of Surgery Department at SSMC, marked another significant achievement in the field of minimally invasive surgery and robotic-assisted procedures. It also further underscores the hospital's commitment to deliver advanced health care solutions centered around personalized care and ......read more

The male infant was born prematurely at 27 weeks via Caesarean section, weighing 900 grams, with the mother having gestational diabetes, a known risk factor for Retinopathy of Prematurity (ROP) Retinopathy of prematurity (ROP) is a common cause of reversible childhood blindness caused by inadequate retinal blood vessel formation in preterm infants. Approximately 32,300 infants worldwide are diagnosed with irreversible vision impairment due to ROP annually, of which approximately 20,000 become blind or severely visually impaired.  Dubai, April 29, 2024: A newly turned 60-week-old blind baby boy with Stage 3 Retinopathy of Prematurity, who was delivered prematurely at 27 weeks via an emergency Caesarean section to a mother with gestational diabetes,  had glimmers of hope in his eyes. This ......read more

Patient in full recovery following the operation by SSMC’s obstetrics and gynecology specialists on a tumor of unusual size Abu Dhabi, UAE, 25 April 2024: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and member of the PureHealth network, recently performed a landmark operation by successfully removing a tumor of unusual size. Despite ovarian tumors of this size (30.5kg) being extremely rare, the 1.5-hour operation was skilfully conducted by Dr. Muhieddine Seoud and SSMC’s obstetrics and gynecological (OB-GYN) surgical team. The operation was a resounding success with the tumor removed in one piece and the patient is now making a full recovery. The 63-year-old patient, a limousine driver from the Philippines, was recently admitted to SSMC via its Emergency ......read more

Medcare Women & Children Hospital (MWCH) in Dubai emerges as the first private healthcare facility in the Middle East, Asia Pacific and Africa region to administer gene therapy infusions to 100 children from around the world suffering from Spinal Muscular Atrophy (SMA) Dubai, April 23, 2024: Medcare Women & Children Hospital (MWCH) in Dubai has announced reaching a milestone record of administering 100 gene therapy infusions on children from around the world suffering from Spinal Muscular Atrophy (SMA), a debilitating condition that affects voluntary muscle movement of children. Medcare Women & Children Hospital emerged as the first private healthcare facility in the Middle East, Asia Pacific, and Africa region to administer 100 gene therapy infusions on children with this rare genetic disorder causing the loss of motor ......read more

Abu Dhabi-UAE. 22 April 2024: A true testament to human perseverance and holistic and tailored medical care, Suhail, an eight-year-old Emirati child with severe speech limitations found his voice for the first time after undergoing a six-month speech therapy programme. The treatment was delivered by Al Mushrif Children’s Specialty Centre in Abu Dhabi, part of the Ambulatory Healthcare Services (AHS) network, a subsidiary of PureHealth, the largest healthcare platform in the Middle East. Suhail was diagnosed with epilepsy, dysarthria and oral dysphagia at just three years old. Despite five years of therapy, he achieved success with sounds and syllables, leaving him unable to express himself fully and battling with basic, essential tasks such as eating. Suhail’s condition is one that impacts millions worldwide, as epilepsy ......read more

Abu Dhabi, 18 April 2024: Abu Dhabi Stem Cells Center (ADSCC) has partnered with Emirates Red Crescent (ERC) to enhance accessibility to bone marrow transplants for patients in need, providing them with treatment and support via the centre’s dedicated Abu Dhabi Bone Marrow Transplant (ADBMT©) Program. Under the partnership, ADSCC will provide medical consultations to patients referred by the medical committee of ERC. In addition, both entities will join efforts in fundraising initiatives aimed at supporting and financing BMT procedures for underprivileged patients. The partnership aims to provide these critical treatments to individuals affected by various blood cancers, blood disorders, and autoimmune diseases like multiple sclerosis, ensuring they receive the highest standard of care and support throughout their ......read more